Profile for Karyopharm Therapeutics Inc. (KPTI)
« Back to company indexKPTI Chatter Timeline
Stock Ticker for KPTI
Most Active Tweeters for KPTI
| User | Tweets |
|---|---|
| @tom_mcdaniels | 12 |
| @TickerReport | 11 |
| @ConsumerFeed | 10 |
| @AmericanBanking | 9 |
| @dispatchtribune | 8 |
Recent Tweets for KPTI
 |
@TranscriptDaily Karyopharm Therapeutics $KPTI Given Average Rating of “Buy” by Brokerages https://t.co/p2l7Ida5GR May 25th 2018, 12:05pm |
 |
@WeekHerald Karyopharm Therapeutics $KPTI Receives Average Rating of “Buy” from Brokerages https://t.co/57BudVvtkr May 25th 2018, 11:05am |
 |
@dailypoliticaln Karyopharm Therapeutics $KPTI Downgraded by Wedbush to Neutral https://t.co/wtjwDiKSu1 May 25th 2018, 9:05am |
 |
@TickerReport Karyopharm Therapeutics $KPTI Lowered to Neutral at Wedbush https://t.co/h4hVPkjoUf May 25th 2018, 9:05am |
 |
@WatchlistN Q1 2019 Earnings Forecast for Karyopharm Therapeutics $KPTI Issued By Wedbush https://t.co/KO8voguym4 May 25th 2018, 8:05am |
 |
@RatingsNetwork Wedbush Sets Karyopharm Therapeutics Q1 2019 Earnings Estimates at ($0.75) EPS. https://t.co/nQrL9degOB $KPTI #KPTI May 25th 2018, 7:05am |
 |
@tom_mcdaniels My take on the Wedbush down grade of $kpti. “ we rated it outperform with a $20 target. It hit our target. We are d… https://t.co/3vaVqoG70l May 25th 2018, 7:05am |
 |
@dakotafinancial Karyopharm Therapeutics Forecasted to Earn FY2019 Earnings of -$2.43 Per Share $KPTI https://t.co/UtOIVltLd5 May 25th 2018, 3:05am |
 |
@ZolmaxNews Research Analysts Offer Predictions for Karyopharm Therapeutics’ FY2018 Earnings $KPTI https://t.co/v74jf9GOqG May 25th 2018, 2:05am |
 |
@ChartMill $KPTI shows a strong growth in Revenue. Over the last 5 years it has been growing by 97.19% yearly.… https://t.co/FiIGZj0jTU May 25th 2018, 12:05am |
|
@pennpenn2323 @ObserverBio I am very happy with my purchase of $KPTI shares below $17.50 :) May 24th 2018, 10:05pm |
|
@dakotafinancial Zacks: Analysts Expect Karyopharm Therapeutics $KPTI Will Post Earnings of -$0.82 Per Share https://t.co/nPOpga00qS May 24th 2018, 3:05pm |
 |
@MarketChmln $KPTI share price decreases -7.8%. See recent news release. https://t.co/zaxhLKZtTu May 24th 2018, 3:05pm |
|
@ZolmaxNews Insider Selling: Karyopharm Therapeutics $KPTI CEO Sells $193,900.00 in Stock https://t.co/2Vkzau1NXH May 24th 2018, 2:05pm |
 |
@Wedbush Wedbush's David Nierengarten, Ph.D. Downgrades Karyopharm Therapeutics $KPTI to #Neutral from #Outperform on Shares… https://t.co/LLcPFycndF May 24th 2018, 12:05pm |
 |
@JUSTUSnatuhwera RT @Briefingcom: $KPTI: Wedbush cuts to Neutral May 24th 2018, 11:05am |
 |
@AlertTrade UP/DOWNGRADES ? $KPTI: Wedbush cuts to Neutral https://t.co/EuvOWJT6kX via ? https://t.co/VS8RO1bzXJ May 24th 2018, 11:05am |
 |
@Briefingcom $KPTI: Wedbush cuts to Neutral May 24th 2018, 11:05am |
 |
@TipRanksFeed 5-star analyst Edward White from H.C. Wainwright rated $KPTI w/a Buy. https://t.co/nmLBuDTNDS May 24th 2018, 10:05am |
 |
@kuritzmike RT @odibro: $KPTI and Antengene Sign Exclusive License Agreement to Develop and Commercialize Selinexor, Eltanexor, Verdinexor and KPT-9274… May 24th 2018, 10:05am |
|
@pennpenn2323 $KPTI loading again at this level May 24th 2018, 9:05am |
|
@tom_mcdaniels $kpti up over 80% this year. Data soon. Just being cautious I guess. They don’t want to stick there neck out. Take… https://t.co/oJCnDDxl1B May 24th 2018, 9:05am |
|
@WeekHerald Karyopharm Therapeutics $KPTI Forecasted to Earn FY2018 Earnings of -$2.67 Per Share https://t.co/yZCTKRjn7a May 24th 2018, 9:05am |
|
@Briefingcom $KPTI: Karyopharm Therapeutics and Antengene enter into exclusive license agreement; KPTI to receive $12 mln upfront https://t.co/nLECmYPuBO May 24th 2018, 9:05am |
 |
@osok762 RT @Karyopharm: $KPTI and Antengene Sign Exclusive License Agreement to Develop and Commercialize Selinexor, Eltanexor, Verdinexor and KPT-… May 24th 2018, 9:05am |
|
@tom_mcdaniels $kpti if this gets out of hand I will be adding today. May 24th 2018, 9:05am |
 |
@Hypocrites_Oath RT @OpenOutcrier: $KPTI (-3.5% pre) Wedbush Downgrades Karyopharm Therapeutics to Neutral. $19 PT https://t.co/3n3cXnc9iO May 24th 2018, 8:05am |
|
@Hypocrites_Oath RT @OpenOutcrier: $KPTI (-3.5% pre) Karyopharm inks product commercialization deal in China valued at up to $162M - SA https://t.co/eip1lA… May 24th 2018, 8:05am |
 |
@OpenOutcrier $KPTI (-3.5% pre) Wedbush Downgrades Karyopharm Therapeutics to Neutral. $19 PT https://t.co/3n3cXnc9iO May 24th 2018, 8:05am |
|
@OpenOutcrier $KPTI (-3.5% pre) Karyopharm inks product commercialization deal in China valued at up to $162M - SA https://t.co/eip1lAAP7a May 24th 2018, 8:05am |
 |
@dispatchtribune Karyopharm Therapeutics $KPTI Forecasted to Earn FY2018 Earnings of -$2.67 Per Share https://t.co/JI4Va3LSLt May 24th 2018, 8:05am |
|
@tom_mcdaniels $kpti Is the weakness today due to Wedbush down grade to neutral or low upfront payment for China? I’m focused on S… https://t.co/LBnLzXABYx May 24th 2018, 8:05am |
 |
@MarketCurrents Karyopharm inks product commercialization deal in China valued at up to $162M https://t.co/GVHiCX5Dyk #premarket $KPTI May 24th 2018, 8:05am |
|
@TranscriptDaily Karyopharm Therapeutics $KPTI Downgraded to “Neutral” at Wedbush https://t.co/JQrRNmANhH May 24th 2018, 7:05am |
 |
@stocknewsdotcom $KPTI Wedbush cuts to neutral https://t.co/UeeTE46trX May 24th 2018, 7:05am |
 |
@scrooge_fs Stock $KPTI has just announced an exclusive agreement #pennyStocks #stocks #stockMarket #StockTrading #trader #News May 24th 2018, 7:05am |
 |
@Karyopharm $KPTI and Antengene Sign Exclusive License Agreement to Develop and Commercialize Selinexor, Eltanexor, Verdinexor… https://t.co/aCrOHG1WCS May 24th 2018, 7:05am |
|
@stocknewsdotcom $KPTI Karyopharm Therapeutics and Antengene enter into exclusive license agreement; KPTI to receive $12 mln upfront https://t.co/mffjX5M9dO May 24th 2018, 7:05am |
 |
@stockelite $KPTI Karyopharm and Antengene Sign Exclusive License Agreement to Develop and Commercialize Selinexor, Eltanexor,… https://t.co/i8Hi3mhnMP May 24th 2018, 7:05am |
 |
@odibro $KPTI and Antengene Sign Exclusive License Agreement to Develop and Commercialize Selinexor, Eltanexor, Verdinexor… https://t.co/TbjrE7a9OZ May 24th 2018, 7:05am |
 |
@GNWLive Karyopharm and Antengene Sign Exclusive License Agreement to Develop and Commercialize Selinexor, Eltanexor $KPTI https://t.co/OSQOx8lifo May 24th 2018, 7:05am |
 |
@BioStocks $KPTI downgraded to Neutral from Outperform at Wedbush. May 24th 2018, 6:05am |
|
@dispatchtribune Karyopharm Therapeutics Forecasted to Earn FY2019 Earnings of -$2.43 Per Share $KPTI https://t.co/QnMCIqv3q4 May 24th 2018, 2:05am |
 |
@OlympiaReport Karyopharm Therapeutics Forecasted to Earn FY2019 Earnings of -$2.43 Per Share $KPTI https://t.co/qFP8NwilXW May 24th 2018, 2:05am |
|
@TranscriptDaily Karyopharm Therapeutics $KPTI Stock Price Down 5.3% After Insider Selling https://t.co/l5tKUUobeK May 24th 2018, 1:05am |
|
@tom_mcdaniels After today there’s only 6 trading days till #SEAL $kpti https://t.co/aS72Cd3DYN May 23rd 2018, 3:05pm |
 |
@registrarjourn Investment Analysts’ Recent Ratings Updates for Karyopharm Therapeutics $KPTI https://t.co/30mL8m7iCx May 23rd 2018, 10:05am |
|
@dispatchtribune Investment Analysts’ Recent Ratings Updates for Karyopharm Therapeutics $KPTI https://t.co/0IFnJ2t9ov May 23rd 2018, 10:05am |
 |
@ConsumerFeed Karyopharm Therapeutics Expected to Post FY2019 Earnings of -$2.43 Per Share $KPTI https://t.co/FujrUwLvRF May 23rd 2018, 7:05am |
|
@RatingsNetwork Cantor Fitzgerald Sets Karyopharm Therapeutics FY2019 Earnings Estimates at ($2.43) EPS. https://t.co/wAbU5QJ8ma $KPTI #KPTI May 23rd 2018, 7:05am |
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.